Related Experiment Video
Updated: May 31, 2026

An Automated Method for Assessing Visual Acuity in Infants and Toddlers Using an Eye-Tracking System
Published on: March 17, 2023
Grating visual acuity results in the early treatment for retinopathy of prematurity study
Insights
Early treatment for retinopathy of prematurity (ROP) benefits type 1 cases, improving visual acuity. However, early treatment for type 2 ROP does not show a significant visual acuity advantage.
Area of Science:
- Ophthalmology
- Neonatal Medicine
- Pediatric Vision
Background:
- Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
- High-risk prethreshold ROP requires careful management to optimize visual outcomes.
- Early intervention strategies are being evaluated to prevent vision loss in premature infants.
Purpose of the Study:
- To compare grating visual acuity at age 6 in infants treated early (ET) versus those managed conventionally (CM) for high-risk prethreshold ROP.
- To determine if early treatment for different types of prethreshold ROP impacts long-term visual acuity.
Main Methods:
- Randomized clinical trial involving infants with bilateral high-risk prethreshold ROP.
- One eye received early treatment (ET), the other conventional management (CM), with crossover if ROP progressed.
- Grating visual acuity was assessed at 6 years of age using Teller acuity cards by masked testers.
Main Results:
- No overall statistically significant difference in grating acuity between ET and CM for all high-risk prethreshold ROP.
- Early treatment (ET) significantly improved grating acuity outcomes in type 1 ROP eyes compared to CM.
- No significant visual acuity benefit was observed with ET in type 2 ROP eyes compared to CM.
Conclusions:
- Early treatment is beneficial for type 1 retinopathy of prematurity, improving grating visual acuity outcomes.
- Conventional management with cautious monitoring for progression is recommended for type 2 ROP, as early treatment did not improve acuity.
- These findings support tailored treatment strategies for ROP based on disease type to preserve vision.
Objective:
To compare grating (resolution) visual acuity at 6 years of age in eyes that received early treatment (ET) for high-risk prethreshold retinopathy of prematurity (ROP) with that in eyes that underwent conventional management (CM).
Methods:
In a randomized clinical trial, infants with bilateral, high-risk prethreshold ROP (n = 317) had one eye undergo ET and the other eye undergo CM, with treatment only if ROP progressed to threshold severity. For asymmetric cases (n = 84), the high-risk prethreshold eye was randomized to ET or CM.
Main Outcome Measure:
Grating visual acuity measured at 6 years of age by masked testers using Teller acuity cards.
Results:
Monocular grating acuity results were obtained from 317 of 370 surviving children (85.6%). Analysis of grating acuity results for all study participants with high-risk prethreshold ROP showed no statistically significant overall benefit of ET (18.1% vs 22.8% unfavorable outcomes; P = .08). When the 6-year grating acuity results were analyzed according to a clinical algorithm (high-risk types 1 and 2 prethreshold ROP), a benefit was seen in type 1 eyes (16.4% vs 25.2%; P = .004) undergoing ET, but not in type 2 eyes (21.3% vs 15.9%; P = .29).
Conclusion:
Early treatment of eyes with type 1 ROP improves grating acuity outcomes, but ET for eyes with type 2 ROP does not. APPLICATION TO CLINICAL MEDICINE: Type 1 eyes should be treated early; however, based on acuity results at 6 years of age, type 2 eyes should be cautiously monitored for progression to type 1 ROP. Trial Registration clinicaltrials.gov Identifier: NCT00027222.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Diabetic Retinopathy
Angle Closure Glaucoma: Treatment

